MedTrace Logo

To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function

NCT03804710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2020-06-04

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate the impact of twice-daily topical application of two different moisturizing creams on skin barrier function for 4 weeks.

Conditions

  • Dry Skin
  • Skin Care

Interventions

DRUG

Developmental moisturizing cream 1

Participants will topically apply developmental moisturizing cream 1

DRUG

Developmental moisturizing cream 2

Participants will topically apply developmental moisturizing cream 2

OTHER

Standard cleanser soap

Participants will cleanse the entire face and both lower legs (between the knees and the ankles)with simple pure soap

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline (for GlaxoSmithKline; Human Genome Sciences Inc., a GSK Company; Sirtris, a GSK Company; Stiefel, a GSK Company; ViiV Healthcare)

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-22
Primary Completion
2019-04-16
Completion
2019-04-16

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03804710 on ClinicalTrials.gov